These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15105100)

  • 1. Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.
    Kaye KS; Gold HS; Schwaber MJ; Venkataraman L; Qi Y; De Girolami PC; Samore MH; Anderson G; Rasheed JK; Tenover FC
    Antimicrob Agents Chemother; 2004 May; 48(5):1520-5. PubMed ID: 15105100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
    Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital.
    Ding J; Ma X; Chen Z; Feng K
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):532-3. PubMed ID: 23726651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
    Oliver A; Pérez-Vázquez M; Martínez-Ferrer M; Baquero F; De Rafael L; Cantón R
    Antimicrob Agents Chemother; 1999 Apr; 43(4):862-7. PubMed ID: 10103192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
    Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.
    Leflon-Guibout V; Speldooren V; Heym B; Nicolas-Chanoine M
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2709-14. PubMed ID: 10991849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.
    Oteo J; González-López JJ; Ortega A; Quintero-Zárate JN; Bou G; Cercenado E; Conejo MC; Martínez-Martínez L; Navarro F; Oliver A; Bartolomé RM; Campos J;
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3874-81. PubMed ID: 24777096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
    Wong JS; Mohd Azri ZA; Subramaniam G; Ho SE; Palasubramaniam S; Navaratnam P
    Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain).
    Pérez-Moreno MO; Pérez-Moreno M; Carulla M; Rubio C; Jardí AM; Zaragoza J
    Clin Microbiol Infect; 2004 Mar; 10(3):234-41. PubMed ID: 15008945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.
    Miró E; Navarro F; Mirelis B; Sabaté M; Rivera A; Coll P; Prats G
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3991-4. PubMed ID: 12435708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.
    Briñas L; Zarazaga M; Sáenz Y; Ruiz-Larrea F; Torres C
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3156-63. PubMed ID: 12234838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
    Blazquez J; Baquero MR; Canton R; Alos I; Baquero F
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2059-63. PubMed ID: 8257123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.
    Ortega A; Oteo J; Aranzamendi-Zaldumbide M; Bartolomé RM; Bou G; Cercenado E; Conejo MC; González-López JJ; Marín M; Martínez-Martínez L; Merino M; Navarro F; Oliver A; Pascual A; Rivera A; Rodríguez-Baño J; Weber I; Aracil B; Campos J
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3576-81. PubMed ID: 22491692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
    Waltner-Toews RI; Paterson DL; Qureshi ZA; Sidjabat HE; Adams-Haduch JM; Shutt KA; Jones M; Tian GB; Pasculle AW; Doi Y
    Antimicrob Agents Chemother; 2011 Feb; 55(2):495-501. PubMed ID: 21135189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.
    Speldooren V; Heym B; Labia R; Nicolas-Chanoine MH
    Antimicrob Agents Chemother; 1998 Apr; 42(4):879-84. PubMed ID: 9559800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community.
    Ahmed SF; Ali MM; Mohamed ZK; Moussa TA; Klena JD
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():22. PubMed ID: 24934873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
    Docobo-Pérez F; López-Cerero L; López-Rojas R; Egea P; Domínguez-Herrera J; Rodríguez-Baño J; Pascual A; Pachón J
    Antimicrob Agents Chemother; 2013 May; 57(5):2109-13. PubMed ID: 23439636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.